The report offers an in-depth analysis of the “Global Rheumatoid Arthritis Market” segmented into global and regional market. For more mail: vikas@konceptanalytics.com

1. Global Rheumatoid Arthritis Market
-----------------------------------------
2016
View Report Details

2. Executive Summary
 Arthritis means inflammation in a joint. Inflammation is a normal immune response in a body. It happens when the body, no longer has the ability
to turn off the inflammatory response and thereby start damaging the healthy tissues of the body.
 Inflammation causes redness, warmth, swelling, and pain within the joint. There are more than 100 different types of arthritis, with different
causes and treatment methods. Major classification of arthritis includes degenerative arthritis, inflammation arthritis, infectious and metabolic
arthritis.
 Rheumatoid arthritis or RA is classified under inflammatory arthritis. It is a chronic autoimmune disease.
 About 1 out of every 5 people who suffer from rheumatoid arthritis get lumps on their skin called rheumatoid nodules. This disease occurs in 4
main stages and can be diagnosed with certain blood tests, medical history, and imaging tests. There is no cure for rheumatoid arthritis, but
there are various treatments available that reduce the pain like drugs, physical exercise or surgery.
 The rheumatoid arthritis market is expected to grow in the coming years with growing demand for better medical facilities and more effective
drugs.
 The US rheumatoid arthritis market dominates the global market with larger number of rheumatoid arthritis patients.
 The key trends of the market include increasing competition from anti-IL6 drugs, rising FDA approvals to RA drugs, use of complementary and
alternative medicines, and increasing share of biosimilars.
 The key factors driving the growth of the RA market includes increasing women population, escalating global ageing population, rising health
care expenditure, rising cigarette consumption, and increasing obese population.
 However, there are certain factors which hinder the growth of the rheumatoid arthritis market like high cost of treatment and high research and
development cost.
 The report offers an in-depth analysis of the “Global Rheumatoid Arthritis Market” segmented into global and regional market.
 Competition is concentrated in the hands of few major pharmaceutical companies. Major RA companies that have been covered in the report
include AbbVie, JNJ, Amgen Inc. and Pfizer Inc.
View Report Details

3. Global Rheumatoid Arthritis market is expected to grow significantly in the coming years driven by several factors including increasing
female population, escalating global health care expenditure, rising FDA approvals, rising cigarette consumption …
 The revenue of the global rheumatoid arthritis market is
expected to be recorded at US$.. billion by 2020,
increasing from US$.. billion in the year 2015. It is
expected to record growth at a CAGR of ..% for the
period spanning from 2015-2020.
 The market for XX is expected to account for revenue
worth US$.. billion by 2020, increasing from US$.. billion
in year 2015.
 XX is expected to record revenue worth US$.. billion by
2020, an increase from US$.. billion in 2015.
 XX is expected to hold the maximum revenue share of
..% in 2016, followed by XX with ..% revenue share in
the year 2016.
Global Rheumatoid Arthritis Market by Drug Class (2015/2020E)
Global Rheumatoid Arthritis Market by Value (2015-2020E)
Global Rheumatoid Arthritis Market Share by Drug (2016E)
2015 2016E 2017E 2018E 2019E 2020E
US$Billion
Revenue Annual Growth
TNF
Inhibitors
Biologics Coxibs NSAIDs DMARDs Other
Therapies
US$Billion
2015 2020E
Humira Enbrel Remicade Orencia Rituxan Actemra Others

4. The regional rheumatoid arthritis markets were driven by increasing ageing population, prevalence of smoking, increased
inactivity...
 The revenue of rheumatoid arthritis market in the US is
expected to be recorded at US$.. billion by 2020,
increasing from US$.. billion in the year 2015, growing at a
CAGR of ..% for the period spanning from 2015-2020.
 The total number of patients with rheumatoid arthritis in
the US is expected to reach .. million by 2020, increasing
from .. million in the year 2015.
 The total rheumatoid arthritis population in the US on XX is
expected to reach .. thousand by 2020, increasing from ..
thousand populations in 2015.
 The population on anti-TNFs in the US is expected to
record a growth at a CAGR of ..% for the period spanning
2015-2020.
The US Rheumatoid Arthritis Patient Prevalence (2015-2020E)
)
The US Rheumatoid Arthritis Market by Value (2015-2020E)
The US Rheumatoid Arthritis Anti-TNF Population (2015-2020E)
2015 2016E 2017E 2018E 2019E 2020E
US$Billion
Revenue Annual Growth
2015 2016E 2017E 2018E 2019E 2020E
Million
RA Population Annual Growth
2015 2016E 2017E 2018E 2019E 2020E
Thousands
Population Annual Growth

5. The global rheumatoid arthritis market is concentrated with major pharmaceutical companies dominating the market
through new drug approval …
• AbbVie had ..% of the market share for the year 2015
and is expected to record a rise of .% by 2020.
• JNJ and PEF are expected to register an increase of .% in
their market share by 2020.
• Enbrel produce by Amgen is expected to record ..% of the
total market share in 2016.
• AbbVie’s Humira is expected to account ..% of the
revenue share in 2016 .
• By 2020, the US population on biologic drug treatment is
expected to reach .. thousand, increasing from ..
thousand in the year 2015.
The US Rheumatoid Arthritis Brand (Company) Share (2016E)
Global Rheumatoid Arthritis Market Share by Company (2015/2020E)
The US Rheumatoid Arthritis Biologics Population (2015-2020E)
AbbVie JNJ Amegn PFE MRK BMY RHHBY GSK Others
Enbrel (Amgen/PFE) Humira (AbbVie) Remicade (JNJ)
Orencia (BMY) Rituxan (Roche) Actemra (Roche)
Xeijanz (PFE) Simponi (JNJ) Cimzia (UCB)
2015 2016E 2017E 2018E 2019E 2020E
Thousands
Population Annual Growth

6. Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T. +91-120-4130959
C: +91-9811715635
vikas@konceptanalytics.com
Contact Us:
www.konceptanalytics.com
Vikas Gupta
BD Manager
These are abridged and sanitized sample pages from the comprehensive report on the “ Global Rheumatoid Arthritis Market-
2016 Edition ”. To know more about this report or for any customized research requirement, please contact the following:
View Report Details